Jamison Private Wealth Management, Inc.
Source: SEC Form 13F · as of Mar 2026Jamison Private Wealth Management, Inc. holds 16 biotech & pharma companies tracked by BioSniper, totaling $91.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$91.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 88,262 | $21.6M |
| LLYELI LILLY & Co | 19,904 | $18.3M |
| ABBVAbbVie Inc. | 59,423 | $12.9M |
| AMGNAMGEN INC | 28,100 | $9.9M |
| CAHCardinal Health Inc. | 25,956 | $5.5M |
| GILDGILEAD SCIENCES, INC. | 31,991 | $4.5M |
| MRKMerck & Co., Inc. | 35,473 | $4.3M |
| PFEPFIZER INC | 93,745 | $2.6M |
| NVSNovartis AG | 16,871 | $2.6M |
| BMYBRISTOL MYERS SQUIBB CO | 40,167 | $2.4M |
| ABTABBOTT LABORATORIES | 15,670 | $1.6M |
| PMPhilip Morris International Inc | 8,209 | $1.4M |
| SNYSanofi | 25,580 | $1.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 3,962 | $1.1M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 18,531 | $1.0M |
| NVONovo Nordisk A/S | 13,919 | $512K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.